The pharmacokinetics of pranlukast in healthy young and elderly subjects

International Journal of Clinical Pharmacology and Therapeutics

Volumn 34, Issue 9, 1996, Pages 375-379

  Brocks, D R ^a,c   Upward, J ^a   Hust, R ^b   Koester F E ^b   Collie, H ^b   Qian, Y ^a   Dennis, M J ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

^b FOCUS Clinical Drug Development GmbH   (Germany)

^c UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

Age; Asthma; Pharmacokinetics; Pranlukast

Indexed keywords

LEUKOTRIENE D4; LEUKOTRIENE RECEPTOR BLOCKING AGENT; PRANLUKAST;

ADULT; AGED; AGING; AREA UNDER THE CURVE; ARTICLE; ASTHMA; CLINICAL TRIAL; DRUG BLOOD LEVEL; DRUG HALF LIFE; DRUG TOLERABILITY; FEMALE; GENDER; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; ASTHMA; CHROMONES; FEMALE; HUMANS; MALE;

EID: 0029819494     PISSN: 09461965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Anonymous 1989 SAS/STAT User's Guide, Version 6, Fourth Edition (Vol 1,2). SAS Institute, Cary
2. Barnes NC, Pujet JC 1995 First clinical experience of the oral leukotriene antagonist, pranlukast SB 205312/ONO 1078 in N. European patients with mild to moderate asthma. Am J Respir Crit Care Med 151: A378
3. Brocks DR, Upward JW, Georgiou P, Stelman G, Doyle E. Allen E, Dennis MJ 1996 The single and multiple dose pharmacokinetics of pranlukast in healthy volunteers. Eur J Clin Pharmacol Accepted
4. Chanarin N, Johnston SL 1994 Leukotrienes as a target in asthma therapy. Drugs 47: 12-24
5. Dennis M, Minthorn E, Stelman G, Collie H, Wargenau M, Moeller M, Must R, Georgiou P, Upward J 1994 Effect of food on the absorption of pranlukast in healthy subjects. Pharm Res 11 (Suppl): S430
6. Frew AJ, Holgate ST 1993 Clinical pharmacology of asthma; implications for treatment. Drugs 46: 847-862
7. Fujimura M, Sakahoto S, Kamis Y, Matsuda T 1993 Effect of a leukotriene antagonist ONO 1078 on bronchial hyperresponsiveness in patients with asthma. Resp Med 87: 133-138
8. 4-antagonist RO 24-5913 after multiple dosing in healthy young and elderly volunteers. Pharm Res 11 (Suppl): S370
9. Massoud N 1984 Pharmacokinetic considerations in geriatric patients. In: Benet LZ, Massoud N, Gambertoglio JG (ed) Pharmacokinetic Basis for Drug Treatment. Raven Press, New York, pp 283-310
10. Mayersohn M 1990 Principles of drug absorption. In: Banker GS, Rhodes CT (ed) Modern Pharmaceutics (2nd ed). Marcel Dekker, New York, pp 23-89
11. Yamaguchi T, Kohrogi H, Honda I, Kawano O, Sugimoto M, Araki S, Ando M 1992 A novel leukotriene antagonist, ONO-1078, inhibits and reverses human bronchial contraction induced by leukotrienes C4 and D4 and antigen in vitro. Am Rev Respir Dis 146: 923-929